Kardigan

Developing precision medicines to treat and cure cardiovascular disease.

Discussion
BiotechnologyPharmaceuticals kardigan.bio ↗

Company facts

Founded
2023
Employees
56
Headquarters
United States
Type
Private
Funding
Series B · $254M · 2025
Subsidiaries
Prolaio